Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Remimazolam and Alfentanil Administration in Gynecological Day Surgery
ChiCTR2500107098Phase 4Recruiting
- Sponsor
- Weifang People's Hospital
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam and alfentanil in None (2 arms), sponsored by Weifang People's Hospital. Primary endpoint: Incidence of adverse reactions during anesthesia induction. Started Aug 2025; status: recruiting.
02
Drugs
remimazolamalfentanil
Beyond the preview
Go deeper on ChiCTR2500107098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107098.